drugset

drugset / Trial / NCT07714187

A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides

NCT07714187 ↗

Phase 1 Not yet recruiting 30 enrolled SecuraBio

NaSequentialOpen-labelTreatment

Summary

This study will evaluate the safety and preliminary efficacy of duvelisib topical gel in participants with early-stage mycosis fungoides.

Timeline

Start: 2027-01
Primary completion: 2028-10
Completion: 2029-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Duvelisib	Small molecule	—	Topical

Indications